PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Anthem BCBSCommercial · Prior Auth · Pharmacy · NY · Oncology, Infectious Disease, Hematology +2 moreHigh impact

[New York] Specialty pharmacy updates — February 2026

Act
by Apr 30, 2026
Effective date
May 1, 2026
Identified
May 18, 2026

Summary

Effective May 1, 2026, Anthem is implementing new prior authorization, quantity limit, and step therapy requirements for 14 specialty pharmacy drugs across multiple therapeutic areas. Patients currently receiving these medications without prior authorization will require PA review going forward. Billing teams must identify claims for these drugs and ensure prior authorization is obtained before or concurrent with claim submission to avoid denials.

Get alerts when payers change rules like this one

We check Anthem BCBS and other payers every day and email you when a change matches your specialty and state.

Get Anthem BCBS alertsPolicy Monitoring is free. No card required.

What to do

by Apr 30, 2026 · 6 steps
01Billing team must implement the following changes.
02Update billing system to flag all claims with HCPCS codes C9399, J3590, J3490, J9999, and J1301 for specialty pharmacy drugs listed in this policy (Aukelso, Bildyos, Bilprevda, Bosaya, Enoby, Eydenzelt, Forzinity, Gammagard Liquid ERC, Inlexzo, Keytruda Qlex, Qivigy, Radicava, Xtrenbo) to require prior authorization before claim submission.
03Create internal workflow requiring providers to submit PA requests for these drugs with dates of service on or after May 1, 2026.
04For oncology drugs (marked with asterisk in policy), route PA requests to Carelon Medical Benefits Management, Inc.; non-oncology drugs route to Anthem's medical specialty drug review team.
05Update claim submission processes to include National Drug Code (NDC) on all specialty pharmacy claims to expedite processing.
06Notify providers that these drugs are transitioning to quantity limit and step therapy review; consult Clinical Criteria document (http://anthem.ly/4pRSK8i) for specific limits and preferred agents.
If missed: Failure to obtain prior authorization will result in claim denials for Anthem commercial plans in New York.

Codes mentioned

C9399J3590J3490J9999J1301

Original notice

[New York] Specialty pharmacy updates — February 2026
providernews.anthem.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account